Showing results (301-310 of 844) with videos related to
Sort By:
Pageof 85
Ageing Research Reviews|June 24, 2024
Stem cell-derived extracellular vesicles as senotherapeuticsEkaterina Rudnitsky, Alex Braiman, Marina Wolfson, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|January 1, 1984
Immunohistochemical localization of galactosyltransferase in the normal human ovary and fallopian tubeB W Davis, E G Berger, G W Locher, et al.Schweizerische Medizinische Wochenschrift|October 24, 1981
[Nausea and vomiting during chemotherapy of malignant tumors]R Joss, R Galeazzi, A Gervasi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysisA Goldhirsch, R D Gelber, R J Simes, et al.Geburtshilfe Und Frauenheilkunde|May 1, 1984
[Intratumoral regional differences in hormone receptor status of breast cancer]G W Locher, B Davis, D T Zava, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.Lancet (London, England)|August 11, 2001
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisB F Cole, R D Gelber, S Gelber, et al.Breast (Edinburgh, Scotland)|December 9, 2003
Tailoring adjuvant treatments for the individual breast cancer patientR D Gelber, M Bonetti, M Castiglione-Gertsch, et al.Schweizerische Medizinische Wochenschrift|February 27, 1982
[Stomach cancer. Spontaneous course, therapy and prognosis]R Joss, A Goldhirsch, M Kappeler, et al.Nature Reviews. Clinical Oncology|June 2, 2009
Breast cancer and pregnancy: how safe is trastuzumab?Hatem A Azim, Fedro A Peccatori, Sarah J Liptrott, et al.Pageof 85